Valuation
- Market cap
- 1,000
- Revenue TTM
- $450,000
- Net income TTM
- $-10,300,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- -2,288.89%
- Debt to equity
- 0.00
Trading
- Volume
- 500
- Avg volume
- —
- Day's range
- $0.00 – $0.00
- Shares out
- 1,753,000
- Stochastic %K
- —
- Beta
- 659.93
- Analysts
- —
- Price target
- —
Company profile
Innoveren Scientific Inc., a medical bioscience company that develops technology in regenerative medicine for limb salvage. It is also developing immunotherapies for ovarian cancer, pancreatic cancer, and mesothelioma. The company was formerly known as H-CYTE, Inc. and changed its name to Innoveren Scientific Inc. in July 2023. The company is headquartered in Tampa, Florida.
- Industry
- Biotechnology
- Sector
- Healthcare
- Phone
- 844 633 6839
- Website
- https://innoverenscientific.com
- Address
- 201 East Kennedy Blvd, Suite 700, Tampa, United States
Latest news
No headlines yet.
